Bud Genius Adds Leading Cannabis Marketing Pro to Lead Company Communications Programs
March 16 2015 - 8:37AM
Business Wire
Randall A. Huft has worked with premier
cannabis companies as a principal architect of growth strategies
and positioning
Bud Genius, Inc. (www.bgmedtech.com) (OTC: RIGH), a leading
laboratory for cannabis testing and profiling, developer of
data-driven rating systems for marijuana strains, brand and retail
development specialist, and licensee of celebrity-endorsed
marijuana and hemp related merchandise, announced today they have
added Randall A. Huft, noted cannabis marketing and communications
expert, to their Executive Team.
Huft is well known in the legal cannabis industry and helped
develop communications strategies and programs that have vaulted
many companies into prominence. He was a consultant to Medbox
during their meteoric rise and helped position the company as one
of the leading stories of the year.
Huft also has a wealth of experience outside of the cannabis
industry, and has worked with Fortune 500 companies, including
United Airlines, Avis Car Rental, American Express, Hyundai,
Walgreen’s, Gateway Computers, Loews Hotels, and AT&T.
“We are pleased to have Randall join our Executive Team and look
forward to his many contributions,” said Angel Stanz, company CEO.
“He shares my vision that moving forward with our 2015 Growth
Initiatives it is vital that we have the best possible marketing,
communications and messaging to keep our various audiences and
investors informed, energized and engaged.”
For more information on Bud Genius, call (855) 723-3283, or
visit BGMedtech.com
About Bud Genius:
An early leader in the cannabis industry, Bud Genius is one of
the first established analytical cannabis laboratories in the
United States. Bud Genius launched to bring vendors together with
doctors, patients, and dispensaries that require certified products
held to demanding standards. Bud Genius’ mission is to expand
across the US and abroad, serving as the beacon of quality for
medical cannabis and adult-use marijuana through the formation of
regional laboratories, strain certification, data collection,
online reporting, and product development.
For more information please visit: www.BudGenius.com
Connect:
Website: www.BudGenius.comInvestor Information:
www.BGMedTech.comTwitter: Twitter.com/BudGenius
Forward Looking Statements:
This press announcement includes "forward-looking statements"
within the meaning of the safe harbor provisions of the United
States Private Securities Litigation Reform Act of 1995. These
statements are based upon the current beliefs and expectations of
company’s management and are subject to significant risks and
uncertainties. Forward-looking statements that can be identified by
such terminology such as "believes," "expects," "potential,"
"plans," "suggests," "may," "should," "could," "intends," or
similar expressions. Such forward-looking statements involve known
and unknown risks, uncertainties and other factors that may cause
the actual results to be materially different from any future
results, performance or achievements expressed or implied by such
statements. In particular, management's expectations could be
affected by, among other things, uncertainties relating to our
success in completing acquisitions, financing our operations,
entering into strategic partnerships, competitive factors, and
other matters. Forward-looking statements speak only as to the date
they are made. The Company does not undertake to update
forward-looking statements to reflect circumstances or events that
occur after the date the forward-looking statements are made.
Bud Genius, Inc.Angel Stanz, 855-723-3283Chief Executive
OfficerPR@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Aug 2024 to Sep 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Sep 2023 to Sep 2024